Medical
Empowering Patients in Sickle Cell Treatment
Empowering Patients in Sickle Cell Treatment Approval The approval of Casgevy, a new gene therapy for sickle cell disorder, has...
Read moreDetailsMental Health Act Reforms Improve Care in the UK
A major shift in the UK's mental health care system is underway with significant reforms to the Mental Health Act,...
Read moreDetailsUK’s Pandemic Early Warning System
The UK is breaking new ground with the world’s first real-time pandemic early warning system. In partnership with Oxford Nanopore,...
Read moreDetailsMedSafetyWeek 2025: Preventing Side Effects
As #MedSafetyWeek 2025 kicks off, a global campaign involving regulators from 94 countries and 107 organisations, the focus is clear:...
Read moreDetailsUK Commits £3 Billion to NHS Revamp
Overhauling the NHS for a Healthier Future The UK government has pledged over £3 billion to update NHS infrastructure and...
Read moreDetailsSugemalimab Gains UK Approval for NSCLC
30 October 2024 – In a significant step for cancer treatment, the UK Medicines and Healthcare products Regulatory Agency (MHRA)...
Read moreDetailsWorld Polio Day: MHRA Leads Detection Training
Today marks World Polio Day, a global reminder of the ongoing fight to eradicate polio. The UK’s Medicines and Healthcare...
Read moreDetailsUK Government Announces Enhanced Interim Compensation for Infected Blood Scandal Victims and Estates
The Government has today opened applications for £100,000 interim compensation payments to the estates of individuals who died as a...
Read moreDetailsUK to Ban Single-Use Vapes by 2025
With a new move to address the rising concerns over youth vaping and environmental degradation, the UK government has announced...
Read moreDetailsUK MHRA Approves Donanemab for Early Alzheimer’s Disease
New news in the fight against Alzheimer’s disease. The Medicines and Healthcare products Regulatory Agency has approved the licence for...
Read moreDetails